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Reperfusion timeBackground/Objectives: Ischemic mitral regurgitation (MR) is an adverse prognostic factor. We aimed to assess
the role of time delay from symptom onset to reperfusion, and the impact of collateral circulation to incidence
of MR in relation to established echocardiographic and clinical risk factors.
Methods: Patients with STEMI presenting within 12 h from symptom onset and treatedwith primary percutane-
ous coronary intervention (PPCI) at Hospital of Lithuanian University of Health Sciences were enrolled. Echocar-
diography was performed after PPCI. Based on MR grade, patients were divided into no signiﬁcant MR (NMR,
grade 0-I MR, N = 102) and ischemic MR (IMR, grade ≥2 MR, N = 71) groups. Well-developed collaterals
were deﬁned as grade ≥2 by Rentrop classiﬁcation. Continuous variables were compared by independent sam-
ples Student's T-test. Multivariate logistic regression analysis was used to identify independent predictors of
ischemic MR.
Results: Time to reperfusion, MI localization, TIMI ﬂow before/after PCI was similar between the groups. IMR
group patients were elder, more often females and non-smokers, had lower body mass index, higher prevalence
of multi-vessel coronary artery disease (CAD), better-developed collateral supply, greater left ventricular end-
diastolic diameter index, left atrial index, pulmonary artery systolic pressure and lower ejection fraction. Multi-
variate logistic regression analysis revealed that ischemic MR is predicted by female gender, well-developed
collateral supply, presence of multi-vessel CAD, and lower EF.
Conclusion: In acute STEMI signiﬁcant MR is unrelated to ischemic time and is predicted by female gender, lower
EF, multi-vessel CAD and well-developed collateral supply to the infarct region.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Early reperfusion strategy in ST-elevationmyocardial infarction (MI)
improves patient outcomes. Time to reperfusion has major impact on
extent of myocardial necrosis, preservation of left ventricular (LV) func-
tion and in preventing LV remodeling [1]. The grade of ischemic mitral
regurgitation (MR) has been shown to correlate to myocardial viability:
the presence of viable myocardium in MI zone reduces LV remodeling
and prevents from development or worsening of MR [2]. However,
moderate or severeMR detected early by echocardiography is indepen-
dently associated with worse long-term prognosis in ST-elevation MI
(STEMI) patients treatedwith primary percutaneous coronary interven-
tion (PCI) [3].Lithuanian University of Health
e).
land Ltd. This is an open access articlIschemic MR is known to be dynamic in nature: only a proportion of
patients develop MR after an ischemic event, and MR may change in
grade on long-term follow-up. Prognostic implications are clinically
relevant while following up post-ST-elevation MI (STEMI) patients
and planning treatment interventions [3,4].
The aim of this studywas to assess the impact of time from symptom
onset to reperfusion therapy and presence of collateral circulation to the
infarct zone to incidence ofMR in acute STEMI patients, and relate these
factors to established echocardiographic and clinical risk criteria.
2. Methods
Patients who presented with ﬁrst ever ST-elevation MI and were
treated with primary percutaneous coronary intervention (PCI) at Hos-
pital of LithuanianUniversity of Health Sciences Kaunas Clinics between
December 2013 and September 2014 were enrolled into the study.
Inclusion criteria were ﬁrst ever manifestation of acute coronary
syndrome, ST-segment elevation on ECG, presentation within 12 he under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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presence of any of the following: previous history of ischemic heart dis-
ease (IHD) (known coronary artery disease, previous MI, PCI, coronary
artery bypass surgery), suboptimal echocardiographic imaging quality,
structural heart valve pathology (including previous valvular surgery),
more than mild aortic valve insufﬁciency, previously known MR. Two
hundred twenty patients met the inclusion criteria. Due to exclusion
criteria the ﬁnal study population consisted of 173 patients.
STEMI diagnosis was conﬁrmed based on patient's history, electro-
cardiographic (ECG) ﬁndings (more than 1 mm ST-segment elevation
on two concordant ECG leads, new left bundle branch block), identiﬁ-
able culprit lesion on coronary angiogram and elevated cardio speciﬁc
serum markers (troponin I) [5]. Location of MI was deﬁned as anterior
(ST-segment elevation in ECG leads V1–V6, culprit lesion in left anterior
descending coronary artery) or inferior/posterior (ST-segment eleva-
tion in ECG leads II, III, aVF, and culprit lesion in right coronary or left
circumﬂex coronary arteries).
All patients were treated according to ESC Guidelines on Myocar-
dial Revascularization [6]: 5000 units of unfractionated Heparin
were administered intravenously, followed by an oral loading dose
of 300 mg of Aspirin and 600 mg of Clopidogrel upon ﬁrst medical
contact. No other antiplatelet or ﬁbrinolytic treatment was adminis-
tered before coronary angiography. All patients were subsequently
treated with primary percutaneous coronary intervention. Beta-
blocker, angiotensin-converting enzyme inhibitor and statin were
administered after reperfusion therapy based on clinical judgement
and ESC recommendations.
The cardiovascular risk factors were recorded using a standard ques-
tionnaire. Arterial hypertension was deﬁned as presence of increased
blood pressure (BP) N140/90 mmHg on serial measurements during
in-hospital stay or current use of anti-hypertensive medication. Diabe-
tes mellitus was conﬁrmed based on established medical history or by
detecting elevated fasting plasma glucose ≥7.0 mmol/l on serial
in-hospital measurements. Dyslipidemia was deﬁned as elevated total
(N5.2 mmol/L) or low-density lipoprotein (LDL) level (N2.59 mmol/L),
or low levels of high-density lipoprotein (HDL) cholesterol
(b1.55 mmol/L). Patientwas considered as a smoker if hewas current-
ly smoking or was a smoker in the past.
Heart failure class on presentation was assessed by Killip classiﬁca-
tion [7]: I – no clinical signs of heart failure, II – rales or crackles in the
lungs, gallop rhythm, elevated jugular venous pressure, III – frank
pulmonary edema, IV – cardiogenic shock or hypotension, evidence of
peripheral vasoconstriction.
Time from symptom onset was obtained from the patient during the
ﬁrst medical contact and documented in the medical health records.
Time of balloon inﬂation was recorded during the primary PCI
procedure.
This study complies with the Declaration of Helsinki, and the locally
appointed ethics committee has approved the research protocol.
Informed consent has been obtained from the subjects to use the
medical data for research purposes.
3. Coronary angiography
One experienced interventional cardiologist evaluated coronary
angiography data of all study participants. Angiographically signiﬁcant
lesion was deﬁned as a luminal narrowing of ≥50% in a major epicardial
vessel with diameter ≥2.5 mm. Culprit lesion was determined based on
angiographic appearance (acute blockage or signiﬁcant luminal
compromise resulting in limitation of antegrade coronary blood ﬂow)
and ECG data (supplied territory corresponding to ST-elevation region
on ECG). Thrombolysis in Myocardial Infarction (TIMI) ﬂow grading
system was used to evaluate myocardial perfusion in the infarct-
related artery before and after PCI: TIMI 0 – absence of any antegrade
ﬂow beyond the occlusion; TIMI 1 – antegrade contrast penetration
beyond the occlusion, with incomplete distal ﬁlling; TIMI 2 – slowantegrade ﬂow ﬁlling the distal segments; TIMI 3 – normal coronary
ﬂow [8]. Rentrop classiﬁcation was used to grade collateral ﬂow to the
culprit artery: 0 – none; 1 – ﬁlling of side branches of the distal artery
via collateral channels without visualization of the epicardial segment;
2 – partial ﬁlling of the epicardial segment via collateral channels; 3 –
complete ﬁlling of the epicardial segment of the artery via collateral
channels [9]. The patientwas considered to havewell-developed collat-
erals if the collaterals to the distal coronary bed were grade ≥2
(Rentrop). Chronic total occlusion (CTO) of a non-infarct-related artery
was ascertained if a complete collateralized blockagewith no antegrade
ﬂow (TIMI 0) of a non-infarct-related artery was found on coronary
angiography which met angiographic and clinical criteria for duration
of N3 months with identiﬁable other STEMI-related culprit lesion.4. Echocardiography
Echocardiography was performed within 72 h from admission
and primary PCI. Mitral regurgitation was assessed according to the
ESC/EACVI guidelines by proximal isovelocity surface area (PISA)meth-
od or semi quantitative color ﬂow Doppler when quantitative assess-
ment of MR was not feasible (unmeasurable PISA, or continuous
Doppler trace) [10]. According to the degree of MR patients were divid-
ed into 2 groups: patients with no signiﬁcantMR (NMR group, grade 0-I
MR, N=102) and patients with ischemicMR (IMR group, grade ≥2MR,
N = 71). Left ventricular end-diastolic diameter (LV EDD) was mea-
sured in parasternal long axis view, at end diastole, on the frame
where LV cavity was largest. LV EDD index (LV EDDi) was calculated
by dividing LV EDD (mm) by body surface area (m2). Myocardial mass
(MM) was calculated by Devereux formula [11]. Myocardial mass
index (MMI) was calculated by dividing MM (g) by body surface area
(m2). LV ejection fraction (EF) was calculated by standard Simpson's bi-
plane method [12]. Wall motion score was evaluated in a 16-segment
model: each segment was assessed in multiple views [13]. Systolic
myocardial motion and thickening was graded as 1 – normokinesis or
hyperkinesis, 2 – hypokinesis, 3 – akinesis, 4 – dyskinesis, 5 – aneurysm.
Total wall motion score was indexed to the total number of segments
analysed [16] to derive the wall motion score index (WMSI). Right
ventricular (RV) diameter was measured in apical 4 chamber view, at
themid-ventricular level of RV, at end diastole. Left atrial (LA) diameter
was estimated at end-systole in parasternal long axis, perpendicularly
to the LAwalls from leading edge of the posterior aorticwall to the lead-
ing edge of the posterior LA wall. LA diameter index (LAi) was obtained
by indexing the measured value to individual BSA. Pulmonary artery
systolic pressure (PASP) was estimated by modiﬁed Bernoulli equation
from tricuspid valve regurgitation velocity [14]. Estimated right atrial
pressure was added according to respiratory variability of inferior
vena cava.5. Statistical analysis
Continuous variables were expressed as mean ± 1 standard devia-
tion and compared with independent samples T-test. Categorical vari-
ables were expressed as frequencies and compared with χ2 test. A
multivariate logistic regression analysis was used to identify the inde-
pendent predictors of ischemic MR development for these parameters:
age, gender, body mass index, LV EDDi, LAi, EF, collateral development
(Rentrop grade 2–3), presence of multi-vessel coronary artery disease
(CAD). The ﬁnal risk stratiﬁcation model was based on selected vari-
ables, which were signiﬁcant at p ≤ 0.05 level for predicting ischemic
MR, following multivariate regression analysis (gender, ejection frac-
tion, collateral supply of Rentrop class ≥2, presence of multi-vessel cor-
onary artery disease) and age. The accuracy of the model predicting
ischemic MR was assessed by the receiver operating characteristic
(ROC) curve.
Table 1
Demographic and clinical proﬁle of 173 patients with ﬁrst ever ST-segment elevation
myocardial infarction.
Variable NMR group
(n = 102)
IMR group
(n = 71)
P
Demographics
Age (years) 62 ± 12.2 69 ± 12.4 b0.001
Gender (male/%) 85/83.3 40/56.3 b0.001
Risk factor proﬁle, comorbidities
Body mass index (kg/m2) 29.2 ± 5.2 27.5 ± 4.4 0.027
Hypertension, n (%) 84 (82.4) 58 (81.7) 0.91
Dyslipidemia, n (%) 91 (89.2) 58 (84.1) 0.33
Diabetes, n (%) 13 (12.7) 7 (9.9) 0.56
Smoking, n (%) 48 (48.5) 14 (21.2) b0.001
Symptom onset to balloon time 4.5 ± 3.0 5.0 ± 3.5 0.38
Immediate presenters (0–3 h), n (%) 43 (42.2) 27 (38.0)
0.46Early presenters (3–6 h), n (%) 27 (26.5) 25 (35.2)
Late presenters (6–12 h), n (%) 32 (31.4) 19 (26.8)
MI localization, n (%)
0.1Anterior 60 (58.8) 33 (46.5)
Inferior/Posterior 42 (41.2) 38 (53.5)
MR — mitral regurgitation, NMR — no MR group, IMR — ischemic MR group, MI —
myocardial infarction. Data is presented as mean ± standard deviation and number
(percentage).
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Patients in IMRgroupwere elder, had lower BMI,weremore likely to
be females and non-smokers (Table 1). Therewas no difference in prev-
alence of arterial hypertension, dyslipidemia and diabetes mellitus be-
tween the groups. Time from symptom onset to reperfusion and
distribution of MI localization was also similar.Table 2
Angiographic data of 173 patients with ﬁrst ever ST-segment elevation myocardial
infarction.
Data NMR group
(n = 102)
IMR group
(n = 71)
P
Coronary dominance, n (%)
Right 79 (77.5) 58 (84.1)
Left 16 (15.7) 6 (8.7) 0.41
Balanced 7 (6.9) 5 (7.2)
Culprit artery, n (%)
Left anterior descending 58 (56.9) 32 (45.1)
Left circumﬂex 9 (8.8) 8 (11.3) 0.31
Right 35 (34.3) 31 (43.7)
No. of affected coronary arteries, n (%)
1 38 (37.3)a 15 (21.1)b
0.022 33 (32.4)a 21 (29.6)a
3 23 (22.5)a 31 (43.7)b
Left main disease 8 (7.8)a 4 (5.6)a
TIMI ﬂow pre-PCI, n (%)
0 61 (59.8) 51 (71.8)
0.44
1 7 (6.9) 3 (4.2)
2 25 (24.5) 13 (18.3)
3 9 (8.8) 4 (5.6)
TIMI ﬂow post-PCI, n (%)
0 0 1 (1.4)
0.4
1 0 1 (1.4)
2 17 (16.7) 11 (15.5)
3 85 (83.3) 58 (81.7)
Collaterals to MI area (Rentrop), n (%)
0 74 (72.5)a 30 (44.1)b
0.01
1 11 (10.8)a 11 (16.2)a
2 14 (13.7)a 19 (27.9)b
3 3 (2.9)a 8 (11.8)b
Presence of chronic total occlusion, n (%) 5 (4.9) 9 (13.2) 0.05
MR — mitral regurgitation, NMR —no MR group, IMR — ischemic MR group, TIMI ﬂow:
thrombolysis in myocardial infarction ﬂow grade, MI—myocardial infarction, PCI: percu-
taneous coronary intervention.Data is presented as number (percentage). a, b—Difference
is statistically signiﬁcant between different letters (a, b) and insigniﬁcant between the
same letters.There was no difference in coronary dominance, culprit artery, TIMI
ﬂow before or after PCI between the groups (Table 2). IMR group pa-
tients had higher prevalence of multi-vessel CAD and better-
developed collateral supply to the infarct region. CTO lesions in non-
culprit arteries were more prevalent in IMR group compared to NMR
group, however statistical signiﬁcance of this ﬁnding was borderline
(p = 0.05).
Patients in IMR group had signiﬁcantly greater LV EDDi, MMI, LAi,
PASP and lower EF (Table 3). WMSI was higher in IMR group. There
was no signiﬁcant difference in MMI, and RV diameters between the
groups.
Therewere signiﬁcantlymore patients presenting in Killip heart fail-
ure class III–IV and higher incidence of in-hospital deaths in IMR group
compared to NMR group (Table 4). In-hospital treatment duration was
also longer in IMR group.
Multivariate logistic regression analysis has shown that in acute
STEMI patients ischemic MR is predicted by female gender, well-
developed collateral supply to ischemic territory, presence of multi-
vessel CAD, and lower EF (Table 5). A model predicting ischemic MR
(including age, gender, ejection fraction, collateral supply of Rentrop
class ≥2 and presence of multi-vessel coronary artery disease) yielded
an area under the ROC curve of 0.84, p b 0.001 (Fig. 1).
7. Discussion
Presence of ischemic MR carries an established adverse prognosis in
acute STEMI patients. Patients at risk are elder, more likely to be female,
to have lower EF and multi-vessel CAD — these ﬁndings are well ac-
knowledged in previous reports [3,4,15]. LA size is a reliable indicator
of LV diastolic function and represents long-standing diastolic LV ﬁlling
status instead of acute variations reﬂected by echocardiographic Dopp-
ler parameters [16,17]. Higher proportion of elderly patients with un-
derlying ‘silent’ ischemic heart disease in IMR group quite naturally
manifests higher degree of diastolic dysfunction indicated by increased
LA index. On the other hand, LA enlargement is common in chronic
volume overload and correlates to both – severity and duration – of
MR [18]; consequently, all possible care during recruitment and
echocardiographic analysis has been taken to exclude possible cases of
previously underlying MR.
Time to reperfusion is an important factor in salvaging the myocar-
dium at risk. Early reperfusion improves immediate and long-term
outcomes in patients who present with STEMI [8,19]. However, ische-
mic time appears to not be directly related to ischemic MR manifesta-
tion in acute STEMI patients treated with primary PCI as has been
shown in our study.
Although recent reports emphasize the importance of collateral sup-
ply in reduction of ischemic MR [20], a considerable proportion of our
study participants exhibited ischemic MR despite well-developed
collateral circulation to occluded culprit artery territory.Table 3
Echocardiographic parameters of 173 patients with ﬁrst ever ST-segment elevation
myocardial infarction.
Parameter NMR group (n = 102) IMR group (n = 71) P
LVEDD, mm 48.3 ± 5.5 48.8 ± 5.8 0.56
LVEDD index, mm/m2 23.7 ± 2.8 25.7 ± 3.2 b0.001
MMI, g/m2 100.5 ± 22.1 110.2 ± 31.4 0.02
EF, % 43.1 ± 8.7 38.6 ± 10.4 0.02
WMSI 1.6 ± 0.4 1.8 ± 0.4 0.04
LA diameter, mm 40.2 ± 4.4 40.6 ± 4.6 0.58
LA index, mm/m2 19.8 ± 2.2 21.6 ± 2.5 b0.001
RV diameter, mm 31.4 ± 5.2 31.8 ± 5.0 0.61
PASP, mmHg 33.1 ± 6.8 39.6 ± 11.2 b0.001
MR — mitral regurgitation, NMR — no MR group, IMR — ischemic MR group, LVEDD: left
ventricular end-diastolic diameter, MMI: myocardial mass index, EF: ejection fraction,
WMSI: wall motion score index, LA: left atrium, RV: right ventricle, PASP: pulmonary
artery systolic pressure. Data is presented as mean ± standard deviation.
Table 4
In-hospital outcomes and distribution of heart failure (Killip) classes in study groups.
Variable NMR
(n = 102)
IMR group
(n = 71)
P
Killip HF class, n (%)
I–II 94 (92.2)a 58 (81.7)b
0.04
III–IV 8 (7.8)a 13 (18.3)b
In-hospital outcomes
In-hospital treatment duration, days 8.1 ± 2.1 9.1 ± 3.0 0.02
In-hospital death, n (%) 1 (1) 5 (7) 0.03
MR — mitral regurgitation, NMR — no MR group, IMR — ischemic MR group. In-hospital
treatment duration is presented as mean ± standard deviation, other data — as number
(percentage). a, b — Difference is statistically signiﬁcant between different letters (a, b)
and insigniﬁcant between the same letters.
Fig. 1. Discriminative power of the prognostic model using age, gender, ejection fraction,
collateral supply and presence of multi-vessel coronary artery disease for the risk stratiﬁ-
cation of ischemicmitral regurgitation in patients with ﬁrst acute ST-elevationmyocardial
infarction. Sensitivity 70.1%. Speciﬁcity 84.5%. Positive predictive value 75.8%. Negative
predictive value 80.4%, p b 0.001.
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and plays protective role in limiting the infarct size and in maintain-
ing hemodynamic stability in acute ischemic events [21,22]. Animal
models have demonstrated that signiﬁcant increase in collateral
blood ﬂow within the infarct area is present during the ﬁrst hour
after coronary artery occlusion, and further increase is observed
upon follow-up [23]. However, human observational studies show
that there is no increase in the prevalence of angiographically visible
collateral ﬂow with increasing time to baseline angiography in acute
MI patients. These ﬁndings suggest that all collateral channels iden-
tiﬁable on baseline angiography most likely had developed due to
preceding high-grade coronary artery stenosis [24]. Higher preva-
lence of multi-vessel CAD and collateral development are also in
keeping with the hypothesis of prior ‘silent’ and unrecognized ische-
mic heart disease with an underlying degree of LV remodeling sug-
gested by larger LV EDDi.
In this study, we tested the hypothesis whether patients with well-
developed collateral circulation to the infarct area have less incidence
of MR due to better-preserved myocardial viability upon presentation
with acute STEMI. The observed effect of collateral circulation to the in-
cidence of MR was quite the opposite from expected: well-developed
collaterals to the infarct region upon presentation do not reduceMR in-
cidence, but are a signiﬁcant independent predictor of functional MR in
STEMI patients. Preventive role of collateral blood supply regarding is-
chemic MR is far negatively outweighed by underlying LV remodeling
as the result of preceding IHD. Prior studies have demonstrated that al-
though gradual development of collaterals can prevent from acute is-
chemic event in the presence of increasing coronary artery
obstruction, collateral ﬂow reserve is rarely sufﬁcient to provide ade-
quatemyocardial perfusion even in stable CAD patientswith chronically
occluded coronary arteries [25–27]. The role of collateral circulation is
even less pronounced in preventing acute ischemia upon abrupt ob-
struction of the coronary vessel in acute ischemic event [28,29].
Which is more, experimental studies have demonstrated that there is
a transmural difference in the effectiveness of collateral supply: collater-
al ﬂow is signiﬁcantly greater in the epicardial than endo- or mid-
ventricular layers, irrespectively of site [30]. However, further studiesTable 5
Odds ratios for grade ≥2 ischemic MR in multivariate logistic regression analysis.
Predictor OR (95% CI) P
Age 1.0 (0.9–1.1) 0.13
Female gender 3.5 (1.4–9.2) 0.01
Body mass index 0.9 (0.9–1.0) 0.26
Collaterals Rentrop class ≥2 2.9 (1.2–7.2) 0.02
Multi-vessel CAD 3.9 (1.4–11.1) 0.02
LV EDDi 1.1 (1.0–1.3) 0.13
LA index 1.2 (1.0–1.5) 0.09
EF 0.9 (0.9–1.0) 0.01
MR — mitral regurgitation, OR — odds ratio, CI — conﬁdence interval, CAD — coronary
artery disease, LV EDDi — left ventricular end-diastolic diameter index, LA — left atrium,
EF— ejection fraction.are needed to assess the impact of collateral ﬂow on ischemic MR on
long-term follow-up.
All patients in our studywere treatedwith primary PCI for culprit le-
sion only. Conventional management strategies for treating STEMI pa-
tients with multi-vessel CAD may vary from complete interventional
revascularization including non-culprit lesions during index procedure
to medical therapy, staged PCI or subsequent surgical revascularization
[31–33]. Impact of completeness of revascularization and residual ische-
mic myocardial burden on ischemic MR is a potential direction for fu-
ture investigations.8. Study limitations
As left ventricular function and degree of ischemic MR may change
on long-term follow-up after myocardial reperfusion therapy, lack of
follow-up of these patients in assessing the impact of collateral ﬂow
on prevalence of ischemic MR is among the limitations of this study.
Presence of MR in some patients may not be related to the acute ische-
mic event despitemultiple exclusion criteria to rule out such cases. Col-
lateral supply may have been underestimated due to competitive ﬂow
physiology in patients with preserved antegrade ﬂow. The population
presented in the study belongs to a single centre.9. Conclusion
In acute ﬁrst-presentation STEMI population presence of signiﬁcant
MR is unrelated to ischemic time and associated with female gender,
lower EF, presence of multi-vessel CAD and well-developed collateral
supply to the MI region.Conﬂict of interest
Authors declare no conﬂict of interest.
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